title: How fast are antidepressants?
abstract: BACKGROUND
  For years, investigators have tried to determine the speed of onset of antidepressant drugs. Claims that particular drugs may produce a faster response in patients than other agents have been made, but such claims have never been confirmed.
  
  
  METHODS
  The authors reviewed reports from studies of the speed of onset of antidepressant therapies and other studies that revealed information on this topic. We compiled a list of factors that can affect the results of such studies and interpretations of study results. In addition, we reviewed literature concerned with methods of speeding up antidepressant responses.
  
  
  RESULTS
  No antidepressant medication currently available has been shown conclusively to have a more rapid onset of action than any other. However, some methods of augmentation may have the potential to speed responses. Somatic therapies such as electroconvulsive therapy, phototherapy, and therapeutic sleep deprivation may be the fastest options available at this time.
  
  
  CONCLUSIONS
  All available antidepressant medications are usually taken for several weeks before future responders will display a significant therapeutic benefit. If a patient does not show at least a 20% improvement within the first 2 to 4 weeks of treatment, the treatment regimen should be altered. For patients who do show early benefits from a medication trial, one can expect additional benefits to accrue over an 8- to 12-week period and to improve overall outcome compared with those slower to respond. Future trials need to address methodological confounds, but a truly "faster antidepressant" will probably require new neuroscience technology.
authors.affiliation: Department of Psychiatry, University of Arizona Health Science Center, Tucson 85724-5002, USA. alang@u.arizona.edu
authors.forename: A J
authors.initials: AJ
authors.lastname: Gelenberg
authors.forename: C L
authors.initials: CL
authors.lastname: Chesen
mesh_terms: D000928:Antidepressive Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D015990:Placebo Effect; D012044:Regression Analysis; D012107:Research Design; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents